Synthetic Biology and Bioengineering Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Department of Biosystems and Bioengineering, KRIBB School of Biotechnology, Korea University of Science and Technology (UST), 217 Gajeong-ro, Yuseong-gu, Daejeon, 34113, Republic of Korea.
Microb Cell Fact. 2021 Dec 28;20(1):232. doi: 10.1186/s12934-021-01725-w.
Proteins with novel functions or advanced activities developed by various protein engineering techniques must have sufficient solubility to retain their bioactivity. However, inactive protein aggregates are frequently produced during heterologous protein expression in Escherichia coli. To prevent the formation of inclusion bodies, fusion tag technology has been commonly employed, owing to its good performance in soluble expression of target proteins, ease of application, and purification feasibility. Thus, researchers have continuously developed novel fusion tags to expand the expression capacity of high-value proteins in E. coli.
A novel fusion tag comprising carbohydrate-binding module 66 (CBM66) was developed for the soluble expression of heterologous proteins in E. coli. The target protein solubilization capacity of the CBM66 tag was verified using seven proteins that are poorly expressed or form inclusion bodies in E. coli: four human-derived signaling polypeptides and three microbial enzymes. Compared to native proteins, CBM66-fused proteins exhibited improved solubility and high production titer. The protein-solubilizing effect of the CBM66 tag was compared with that of two commercial tags, maltose-binding protein and glutathione-S-transferase, using poly(ethylene terephthalate) hydrolase (PETase) as a model protein; CBM66 fusion resulted in a 3.7-fold higher expression amount of soluble PETase (approximately 370 mg/L) compared to fusion with the other commercial tags. The intact PETase was purified from the fusion protein upon serial treatment with enterokinase and affinity chromatography using levan-agarose resin. The bioactivity of the three proteins assessed was maintained even when the CBM66 tag was fused.
The use of the CBM66 tag to improve soluble protein expression facilitates the easy and economic production of high-value proteins in E. coli.
通过各种蛋白质工程技术开发的具有新功能或高级活性的蛋白质,必须具有足够的溶解度以保持其生物活性。然而,在大肠杆菌中异源表达蛋白质时,经常会产生无活性的蛋白质聚集体。为了防止包涵体的形成,融合标签技术已被广泛应用,因为它在目标蛋白的可溶性表达、应用简便性和纯化可行性方面表现良好。因此,研究人员不断开发新的融合标签,以扩大大肠杆菌中高价值蛋白质的表达能力。
开发了一种包含碳水化合物结合模块 66(CBM66)的新型融合标签,用于在大肠杆菌中可溶性表达异源蛋白。使用七种在大肠杆菌中表达量低或形成包涵体的蛋白质(四种人类来源的信号多肽和三种微生物酶)验证了 CBM66 标签的目标蛋白可溶性。与天然蛋白相比,CBM66 融合蛋白的可溶性和高生产滴度均有所提高。使用聚对苯二甲酸乙二醇酯水解酶(PETase)作为模型蛋白,将 CBM66 标签的蛋白溶解效果与两种商业标签(麦芽糖结合蛋白和谷胱甘肽 S-转移酶)进行了比较;与其他商业标签融合相比,CBM66 融合导致可溶性 PETase 的表达量提高了 3.7 倍(约 370mg/L)。通过用肠激酶进行连续处理并使用纤维二糖琼脂糖树脂进行亲和层析,从融合蛋白中纯化得到完整的 PETase。即使融合了 CBM66 标签,三种蛋白质的生物活性也得以维持。
使用 CBM66 标签提高可溶性蛋白表达,便于在大肠杆菌中轻松且经济地生产高价值蛋白。